CY2023 Q1
Loading, please wait
Company
|
Value
|
End Date
|
SEC Filing
|
|---|---|---|---|
| 1st Source Corp | $1,557,272,000.00 | 2023-03-31 | View |
| 2seventy bio, Inc. | $75,450,000.00 | 2023-03-31 | View |
| 4D Molecular Therapeutics, Inc. | $50,305,000.00 | 2023-03-31 | View |
| A10 NETWORKS, INC. | $28,977,000.00 | 2023-03-31 | View |
| ABSCI CORP | $0.00 | 2023-03-31 | View |
| ACNB CORPORATION | $435,769,000.00 | 2023-03-31 | View |
| Acrivon Therapeutics, Inc. | $0.00 | 2023-03-31 | View |
| Acumen Pharmaceuticals, Inc. | $23,755,000.00 | 2023-03-31 | View |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | $142,372,000.00 | 2023-03-31 | View |
| AEGLEA BIOTHERAPEUTICS, INC. | $0.00 | 2023-03-31 | View |
| AEROVATE THERAPEUTICS, INC. | $10,488,000.00 | 2023-03-31 | View |
| Affinity Bancshares, Inc. | $38,374,000.00 | 2023-03-31 | View |
| Affirm Holdings, Inc. | $33,690,000.00 | 2023-03-31 | View |
| Airbnb, Inc. | $12,500,000.00 | 2023-03-31 | View |
| ALERUS FINANCIAL CORPORATION | $679,981,000.00 | 2023-03-31 | View |
| ALIGN TECHNOLOGY, INC. | $77,077,000.00 | 2023-03-31 | View |
| Ally Financial Inc. | $25,577,000,000.00 | 2023-03-31 | View |
| Alphabet Inc. | $44,382,000,000.00 | 2023-03-31 | View |
| ALPINE IMMUNE SCIENCES, INC. | $33,110,000.00 | 2023-03-31 | View |
| ALX ONCOLOGY HOLDINGS INC | $28,400,000.00 | 2023-03-31 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations